Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email in the first instance.

 Information  X 
Enter a valid email address

Virotec Intl. PLC (VTI)

  Print      Mail a friend

Wednesday 30 August, 2006

Virotec Intl. PLC

Admission to AIM

Virotec International PLC
30 August 2006

30 August 2006

                           VIROTEC INTERNATIONAL PLC

                          ADMISSION TO TRADING ON AIM

Virotec International plc ('Virotec' or the 'Company') (AIM: VTI), was admitted
to trading on AIM as from 8.00am on Wednesday 30 August 2006.

Virotec is the successor entity to Virotec International Ltd ('Virotec (Aus)'),
a company which has been listed on AIM since July 2001, following implementation
of the Scheme of Arrangement described below. Virotec now owns Virotec (Aus) and
its subsidiaries.  The AIM listing of Virotec (Aus) was cancelled on 30 August

Virotec's Nominated Adviser and Broker is Numis Securities Limited.

Commenting on today's announcement, Executive Chairman Brian Sheeran noted, 'Now
that Virotec is a company incorporated in England, many new and existing
investors on AIM may find Virotec a more appealing investment'.

Looking forward, Mr Sheeran commented, 'We remain very excited about Virotec's
prospects, particularly in the water treatment sector where significant
development and commercialisation has taken place in the USA for the reduction
of naturally occurring radium in drinking water.  The treatment of contaminated
waste market, both liquid and solid, continues to grow and is a primary target
for Virotec. New manufacturing facilities in the USA and Italy have been
established to cater for the expected demand in reagents required for roll out
of solutions to clients for previously intractable problems.'

'We will continue to identify business drivers to develop and implement
sustainable outcomes for our clients.'

Scheme of Arrangement

On 1 June 2006, the directors of Virotec (Aus) announced its intention to change
the domicile of the Virotec Group from Australia to England to, among other
things, further Virotec (Aus)'s evolution into a truly international company.
This change reflects the move of Virotec (Aus)'s shareholder base away from
Australia, with approximately 79% of the issued share capital of Virotec (Aus)
held by shareholders resident in the UK and Europe.

Virotec (Aus) effected the change of domicile through a scheme of arrangement
under the Australian Corporations Act 2001, involving a share exchange with
Virotec, a company newly incorporated in England and Wales and established for
this purpose (the 'Scheme'). The Explanatory Statement, which contains complete
details of the Scheme, including an independent expert's report, was sent to
shareholders and released to the market on 28 June 2006, and is available at The Virotec (Aus) Annual Report for the year ended 30 June 2005
which includes audited financial statements was distributed to shareholders, and
is available at

The Scheme was subject to many conditions, including shareholder approval
(received on 31 July 2006) and Supreme Court of Queensland approval (following
hearings on 19 June and 17 August 2006).  All conditions have now been satisfied
and the Scheme has been implemented.  Virotec (Aus) is now wholly owned by

Following implementation of the Scheme, Virotec now owns all of the issued
shares in Virotec (Aus) and the existing Virotec (Aus) shareholders have been
allotted one fully paid Ordinary Share in Virotec for each share previously held
in Virotec (Aus). As a result, Virotec has a total of 240,162,442 Ordinary
Shares on issue.

For further information in relation to this transaction, please refer to
previous announcements by Virotec which can be viewed on Virotec's website at

No funds have been raised as a result of the Scheme.  In addition, 11,460,000
options have been issued to employees to replace options previously granted by
Virotec (Aus) which have been cancelled.  The options have been issued on
substantially the same terms as the options originally issued by Virotec (Aus).

Business overview

There are no changes to the business of the Virotec Group as a result of
implementation of the Scheme. The business activities of Virotec are described
on Virotec's website at and are primarily the development and
exploitation of environmental technologies including the delivery of commercial,
environmentally sustainable solutions for the treatment of water and soils.
These activities and technologies are described further in the Explanatory
Statement and the 2005 Annual Report of Virotec (Aus).

Current trading and prospects

Following implementation of the Scheme, Virotec has no assets other than the
shares in Virotec (Aus) acquired under the Scheme.  Accordingly, the trading and
prospects of Virotec are the same as Virotec (Aus) and its subsidiaries.

For further information in relation to the Scheme of Arrangement or Virotec
generally, please visit or email enquiries to

                           Virotec International plc
                             Company Number 5796515
                                   PO Box 188
                            Sanctuary Cove Qld 4212

                      This information is provided by RNS
            The company news service from the London Stock Exchange

a d v e r t i s e m e n t